NeuroICU FastTrack: Rapid Disposition of Patients with Intracerebral Hemorrhage from the Emergency Department to

Nicolle W Davis1, Jeannette M Hester2, Brandon Allen3

  • 1Comprehensive Stroke Center, University of Florida Health Shands Hospital, Gainesville, FL, USA. wilsnm@shands.ufl.edu.

Neurocritical Care
|April 25, 2025
PubMed

Insights

Implementing the NeuroICU FastTrack pathway significantly reduced emergency department length of stay for intracerebral hemorrhage patients, leading to decreased mortality rates.

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Health Services Research

Background:

  • Prolonged emergency department length of stay (EDLOS) is linked to increased mortality in critically ill patients.
  • Intracerebral hemorrhage (ICH) patients experience worse outcomes with extended EDLOS.
  • Reducing EDLOS is crucial for improving patient outcomes.

Purpose of the Study:

  • To implement an expedited triage pathway for ICH patients.
  • To reduce EDLOS to under 3 hours.
  • To evaluate the impact on morbidity and mortality.

Main Methods:

  • Retrospective analysis of ICH patients from January 2022 to June 2023.
  • Utilized univariate and multivariate logistic regression.
  • Investigated the association of the NeuroICU FastTrack intervention with EDLOS and mortality.

Main Results:

  • EDLOS decreased significantly from 6.6 to 4 hours post-intervention (p < 0.001).
  • In-hospital mortality reduced from 22.9% to 9.3% (p = 0.006).
  • Morbidity (mRS 0-2) remained stable (23% pre-intervention vs. 28% post-intervention).

Conclusions:

  • Shorter EDLOS for ICH patients significantly decreases mortality.
  • The NeuroICU FastTrack pathway improves patient throughput and outcomes.
  • No significant difference in morbidity was observed in this population.
Abstract

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...